2-Bromo-5-phenyl-1,3,4-oxadiazole

Introduction

CAS No. :	51039-53-3	MDL No. :	MFCD06660932
Formula :	C8H5BrN2O	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	XMTNHCRGHQLOEX-UHFFFAOYSA-N
M.W :	225.04	Pubchem ID :	16227452
Synonyms :

Physicochemical Properties

Num. heavy atoms :	12
Num. arom. heavy atoms :	11
Fraction Csp3 :	0.0
Num. rotatable bonds :	1
Num. H-bond acceptors :	3.0
Num. H-bond donors :	0.0
Molar Refractivity :	47.43
TPSA :	38.92 Ų

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	No
CYP1A2 inhibitor :	Yes
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-5.54 cm/s

Lipophilicity

Log Po/w (iLOGP) :	2.14
Log Po/w (XLOGP3) :	3.0
Log Po/w (WLOGP) :	2.5
Log Po/w (MLOGP) :	2.08
Log Po/w (SILICOS-IT) :	2.62
Consensus Log Po/w :	2.47

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	0.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-3.74
Solubility :	0.0412 mg/ml ; 0.000183 mol/l
Class :	Soluble
Log S (Ali) :	-3.48
Solubility :	0.0742 mg/ml ; 0.00033 mol/l
Class :	Soluble
Log S (SILICOS-IT) :	-4.24
Solubility :	0.0129 mg/ml ; 0.0000571 mol/l
Class :	Moderately soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	1.0
Synthetic accessibility :	2.25

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P280-P305+P351+P338	UN#:	N/A
Hazard Statements:	H302-H315-H319-H332-H335	Packing Group:	N/A
GHS Pictogram:

Related View all 

• 

  Ghk-Cu

• 

  Gly-His-Lys acetate salt

• 

  N-Phenylacetyl-L-Prolylglycine ethyl ester

• 

  L-Phenylalanyl-L-isoleucine

• 

  L-Isoleucyl-L-phenylalanine

• 

  L-Ala-L-phe

• 

  L-Glutathione Reduced

• 

  L-Alanyl-L-tyrosine